Long-term outcome data is still stronger for the injections, especially semaglutide, which has dedicated cardiovascular outcome data from the SELECT trial
Farmasi L-Carnitine Im really excited to educate a bit on my favorite product
The good news: in addition to enhanced glycemic control and weight loss, cardiovascular outcomes trials (CVOT) with GLP-1 RAs suggest a positive impact on several cardiovascular risk factors for patients with T2D
however, rates of discontinuation due to GI AEs are thought to be higher in clinical practice
To make the medicine more effective and for general health benefits, stop smoking, maintain a healthy weight, and do not drink too much alcohol
Do not use: if you have bloody or black stools if you have difficulty swallowing Ask a doctor before use if you have: fever mucus in the stool a history of liver disease a history of abnormal heart rhythm Ask a doctor before use if you are taking a prescription drug